vs
BANNER CORP（BANR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是BANNER CORP的1.2倍（$197.9M vs $169.3M），BANNER CORP净利率更高（32.3% vs 6.7%，领先25.6%），REPLIGEN CORP同比增速更快（13.6% vs 5.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.0%）
Banner Corp是总部位于美国华盛顿州沃拉沃拉的商业银行主体，旗下Banner银行的经营历史可追溯至1890年。业务覆盖商业地产、建筑、住宅、农业及消费贷款领域，还通过分布在华盛顿州、俄勒冈州、爱达荷州和加利福尼亚州的网点及贷款办事处提供社区银行服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BANR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$169.3M
营收增速更快
RGEN
高出7.9%
5.7%
净利率更高
BANR
高出25.6%
6.7%
两年增速更快
RGEN
近两年复合增速
13.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $169.3M | $197.9M |
| 净利润 | $54.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 32.3% | 6.7% |
| 营收同比 | 5.7% | 13.6% |
| 净利润同比 | 21.2% | 143.9% |
| 每股收益（稀释后） | $1.60 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BANRRGEN
| Q1 26 | $169.3M | — | ||
| Q4 25 | $152.4M | $197.9M | ||
| Q3 25 | $150.0M | $188.8M | ||
| Q2 25 | $144.4M | $182.4M | ||
| Q1 25 | $141.1M | $169.2M | ||
| Q4 24 | $140.5M | $174.1M | ||
| Q3 24 | $135.7M | $154.9M | ||
| Q2 24 | $132.5M | $154.1M |
净利润BANRRGEN
| Q1 26 | $54.7M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $53.5M | $14.9M | ||
| Q2 25 | $45.5M | $14.9M | ||
| Q1 25 | $45.1M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $45.2M | $-654.0K | ||
| Q2 24 | $39.8M | $3.3M |
毛利率BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 9.0% | ||
| Q3 25 | 13.8% | 8.9% | ||
| Q2 25 | 12.3% | 7.6% | ||
| Q1 25 | 13.5% | 3.9% | ||
| Q4 24 | 14.3% | -17.7% | ||
| Q3 24 | 13.3% | -5.1% | ||
| Q2 24 | 13.0% | 1.0% |
净利率BANRRGEN
| Q1 26 | 32.3% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 35.7% | 7.9% | ||
| Q2 25 | 31.5% | 8.2% | ||
| Q1 25 | 32.0% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 33.3% | -0.4% | ||
| Q2 24 | 30.0% | 2.2% |
每股收益（稀释后）BANRRGEN
| Q1 26 | $1.60 | — | ||
| Q4 25 | $1.49 | $0.24 | ||
| Q3 25 | $1.54 | $0.26 | ||
| Q2 25 | $1.31 | $0.26 | ||
| Q1 25 | $1.30 | $0.10 | ||
| Q4 24 | $1.34 | $-0.55 | ||
| Q3 24 | $1.30 | $-0.01 | ||
| Q2 24 | $1.15 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $16.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | $422.6M | $767.6M | ||
| Q3 25 | $672.9M | $748.7M | ||
| Q2 25 | $483.3M | $708.9M | ||
| Q1 25 | $441.9M | $697.2M | ||
| Q4 24 | $501.9M | $757.4M | ||
| Q3 24 | $478.8M | $784.0M | ||
| Q2 24 | $247.5M | $809.1M |
总债务BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BANRRGEN
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.9B | $2.1B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.8B | $2.0B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.7B | $2.0B |
总资产BANRRGEN
| Q1 26 | $16.3B | — | ||
| Q4 25 | $16.4B | $2.9B | ||
| Q3 25 | $16.6B | $2.9B | ||
| Q2 25 | $16.4B | $2.9B | ||
| Q1 25 | $16.2B | $2.9B | ||
| Q4 24 | $16.2B | $2.8B | ||
| Q3 24 | $16.2B | $2.8B | ||
| Q2 24 | $15.8B | $2.9B |
负债/权益比BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | $257.5M | $25.7M | ||
| Q3 25 | $120.4M | $48.1M | ||
| Q2 25 | $54.9M | $28.6M | ||
| Q1 25 | $57.2M | $15.0M | ||
| Q4 24 | $293.2M | $39.2M | ||
| Q3 24 | $63.8M | $49.3M | ||
| Q2 24 | $78.7M | $42.2M |
自由现金流BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $17.6M | ||
| Q3 25 | $118.7M | $43.4M | ||
| Q2 25 | $52.1M | $21.5M | ||
| Q1 25 | $55.6M | $11.4M | ||
| Q4 24 | $279.4M | $33.6M | ||
| Q3 24 | $60.4M | $42.3M | ||
| Q2 24 | $74.3M | $37.4M |
自由现金流率BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 162.6% | 8.9% | ||
| Q3 25 | 79.1% | 23.0% | ||
| Q2 25 | 36.1% | 11.8% | ||
| Q1 25 | 39.4% | 6.8% | ||
| Q4 24 | 198.8% | 19.3% | ||
| Q3 24 | 44.5% | 27.3% | ||
| Q2 24 | 56.0% | 24.3% |
资本支出强度BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 1.9% | 3.9% | ||
| Q1 25 | 1.2% | 2.1% | ||
| Q4 24 | 9.8% | 3.2% | ||
| Q3 24 | 2.5% | 4.5% | ||
| Q2 24 | 3.3% | 3.1% |
现金转化率BANRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.25× | 3.23× | ||
| Q2 25 | 1.21× | 1.92× | ||
| Q1 25 | 1.27× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.98× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
